GLP-1 receptor agonists for Parkinson's disease?

被引：0
|
作者：
不详
机构：
来源：
PROGRESS IN NEUROLOGY AND PSYCHIATRY | 2020年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [1] GLP-1 receptor agonists for Parkinson's disease
    Mulvaney, Caroline A.
    Duarte, Goncalo S.
    Handley, Joel
    Evans, David J. W.
    Menon, Suresh
    Wyse, Richard
    Emsley, Hedley C. A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (07):
  • [2] GLP-1 receptor agonists: A revolution in the treatment of Parkinson's disease?
    Javed, Dawood
    Jajja, Faran Ahmed
    Javed, Abdullah
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2024, 86 : 11 - 12
  • [3] GLP-1 Receptor Agonists: A New Treatment in Parkinson's Disease
    Kalinderi, Kallirhoe
    Papaliagkas, Vasileios
    Fidani, Liana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [4] Therapeutic application of GLP-1 and GIP receptor agonists in Parkinson's disease
    Yang, Xiaoyan
    Feng, Peng
    Ji, Rong
    Ren, Yiqing
    Wei, Wenshi
    Holscher, Christian
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (05) : 445 - 460
  • [5] Repurposing GLP-1 Receptor Agonists for Parkinson's Disease: Current Evidence and Future Opportunities
    Victorino, Daniella Balduino
    Nejm, Mariana
    Guimaraes-Marques, Marcia
    Scorza, Fulvio Alexandre
    Scorza, Carla Alessandra
    PHARMACEUTICAL MEDICINE, 2021, 35 (01) : 11 - 19
  • [6] Repurposing GLP-1 Receptor Agonists for Parkinson’s Disease: Current Evidence and Future Opportunities
    Daniella Balduino Victorino
    Mariana Nejm
    Marcia Guimarães-Marques
    Fulvio Alexandre Scorza
    Carla Alessandra Scorza
    Pharmaceutical Medicine, 2021, 35 : 11 - 19
  • [7] The role of GLP-1/GIP receptor agonists in Alzheimer's disease
    Yu, Chun Jiang
    Ma, Dongying
    Song, Ling Ling
    Zhai, Zhen Nan
    Tao, Ye
    Zhang, Ying
    Cai, Ling Yu
    Hou, Ya Hui
    Chen, Hong Yuan
    Wang, Li
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 29 (06): : 661 - 668
  • [8] GLP-1 Receptor Agonists in Diabetic Kidney Disease
    Michos, Erin D.
    Tuttle, Katherine R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (10): : 1578 - 1580
  • [9] Glucagon-like peptide-1 (GLP-1)-based receptor agonists as a treatment for Parkinson's disease
    Glotfelty, Elliot J.
    Olson, Lars
    Karlsson, Tobias E.
    Li, Yazhou
    Greig, Nigel H.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (06) : 595 - 602
  • [10] The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson?s Disease
    Zhang, Lingyu
    Zhang, Liping
    Li, Yanwei
    Li, Lin
    Melchiorsen, Josefine Ulrikke
    Rosenkilde, Mette
    Holscher, Christian
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (02) : 523 - 542
12345